ANIMAL HEALTH NEWS-March

Ceva Saúde Animal Brazil participated in an event organized by Avinews, discussing sustainable egg production in S?o Paulo. Hill’s Pet Nutrition partnered with the Association for Pet Obesity Prevention to promote pet weight management. Vetnil celebrated its 30th anniversary with a biographical book highlighting its journey. Mars do Brasil invested R$30 million in a new distribution center in Minas Gerais to expand pet food logistics. Boehringer Ingelheim launched VAXXITEK HVT+IBD+H5, a new trivalent poultry vaccine, while Zoetis received a conditional USDA license for its H5N2 Avian Influenza Vaccine. MSD Animal Health Spain hosted a conference on pork and poultry industry challenges, and Alltech introduced Planet of Plenty LLC to advocate for sustainable agriculture.

Elanco reported six consecutive quarters of growth, introduced Elura for feline chronic kidney disease in Brazil, and expanded Zenrelia? to new markets. The FDA issued a warning letter to Elanco regarding Zenrelia’s promotional materials but noted no impact on revenue. ECO Animal Health sold non-core licenses in Southern Africa, while Kradle launched Cat Wellness Licks with CBD and non-CBD formulas. Vetanco unveiled a redesigned website for better veterinary industry access, and Mervue Laboratories showcased innovative animal nutrition solutions at VIV Asia 2025. Meanwhile, Hikma Pharmaceuticals USA received FDA approval for a generic Tulathromycin Injection for cattle and swine.

#animalhealth #business #latinamerica #sales #regulatoryaffairs #events #news #launches #management #industry #bernardootero #animalhealthnexus

?? Ceva Saúde Animal Brazil and partners connected to the demands of sustainable egg production. A meeting promoted by Avinews in the capital of S?o Paulo brought a unique program with relevant topics for the laying hens sector. The event was promoted by Avinews and held at Terra?o Itália on February 12, in the capital of S?o Paulo, bringing together some of the main leaders in the commercial laying hens sector. Representing the company were Branko Alva, Director of the Poultry Business Unit; Felipe Pelicioni, Marketing Manager for Long Cycle Poultry at Ceva Brazil; Fernando Resende, Manager of Veterinary Services for Layers; and Pollyana Arruda, National Sales Manager at Ceva Saúde Animal. (opresenterural.com.br, Feb. 18th).

?? Hill's Pet Nutrition and the Association for Pet Obesity Prevention (APOP) announced they are combining their expertise in pet nutrition, veterinary medicine and pet parent education to empower and encourage a supportive environment for achieving and maintaining healthy weight in pets. (prnewswire).

?? Vetnil do Brasil celebrates 30 years of history with a biographical book. Between dreams, tragedies and overcoming, the publication narrates the legacy of one of the main companies in the pet market. Vetnil completed 30 years of history in 2024 and, among the actions that were part of the celebrations of this milestone, the company has just launched a biographical book, available in a web version, with the aim of portraying the most relevant moments of this trajectory marked by dreams, tragedies, twists and turns and a lot of overcoming. From the personal and professional journey of Dr. Jo?o Carlos Ribeiro (in memoriam), its founder, to his early departure in a tragic plane crash, the transition of leadership to his wife, Vera Ribeiro, and the growth of the business, the narrative was told by the writer Barbara Reis and published by Foi Assim, a company specialized in business and personal biographies. (caesegatos.combr, Feb 19th). Alltech has launched Planet of Plenty LLC, a new business entity dedicated to science-led storytelling, advocacy and educational initiatives that amplify agriculture’s vital role in creating a sustainable future. Planet of Plenty will serve as a collaborative hub for those within the agri-food community and beyond. Planet of Plenty’s flagship project is World Without Cows, a feature-length documentary. (Feedstuffs).

?? Mars do Brasil announces R$30 million investment and opens its first operation in Minas Gerais. The company opens a Distribution Center in the city of Extrema, which will be responsible for serving the South, Southeast and Central-West regions. Focused on its growth strategy in the pet food segment in Brazil, Mars, a global leader in the food sector and owner of well-known brands around the world, such as Pedigree, Whiskas, Dreamies and Optimum, opens its new Distribution Center (DC), located in Extrema, Minas Gerais. With investments of R$30 million focused on operational, structural and technological services, the new DC expands Mars Pet Nutrition's direct service coverage capacity and brings technological innovations to the pet food sector. The Distribution Center, which occupies an area of 6,000 m2, will generate more than 100 direct and indirect jobs, and aims to expand Mars Pet Nutrition's logistics and service capacity, supporting the growth of the business's sales in the South, Southeast and Central-West regions. (caesegatos.com.br, Jan).

?? The FDA recently issued a Warning Letter to Elanco related to statements in Zenrelia (ilunocitinib tablets) promotional materials. This letter is not related to the in-market product use experience, and Elanco does not expect the adjustments to the promotional materials to have a material impact on Zenrelia revenue. For full prescribing information for Zenrelia, including the boxed warning, click here. (company press release).

?? Vetanco Argentina presents its new website. The new website of the Vetanco laboratory has new features that will facilitate access to relevant information from the veterinary industry. The animal health company presents a new design of its website, www.vetanco.com, making it a more accessible, modern platform with optimized navigation, designed to provide a unique experience to its users. Vetanco's new website will be much easier to navigate, faster and more user-friendly for mobile devices, allowing users to access information quickly and efficiently, from anywhere. (motivar.com.ar, Feb. 22th).

?? Boehringer Ingelheim announced the launch of VAXXITEK HVT+IBD+H5, a new trivalent vaccine for poultry that offers protection against Marek’s disease, Infectious Bursal Disease and H5 avian influenza in one shot. The vaccine will first launch in Egypt in February 2025. VAXXITEK HVT+IBD+H5 is manufactured in the US where it has been licensed since 2023; however, avian influenza vaccination is currently not permitted in the US. (company press release).

?? MSD Animal Health Spain held a conference with leaders from the Spanish pork and poultry meat sectors. More than 60 managers and technical directors from the pork and poultry meat sectors participated in a conference focused on better understanding the challenges that both sectors of the Spanish meat industry are facing. MSD Animal Health held the “II Conference for Managers: Challenges of Pork and Poultry Production in the 21st Century.” The event and its different sessions were focused on promoting dialogue around the needs of producers in the pork and poultry industry. (3tres3.com, 24th Feb.).

?? Boehringer Ingelheim Australia has launched a new free, interactive digital risk checker tool called PetGard Pro to help dog and cat owners assess their pets’ parasite risk in the Australian market. It also provides recommendations on how owners can protect their pet and the whole family. (vetpracticemag.com.au).

?? The International Fair for Pet Professionals, Iberzoo Propet 2025, closed its eighth edition on February 28 - 16th in the case of Propet - with a record number of participants. A total of 21,612 professionals from the pet sector visited the Show, which showcased the latest developments from 281 companies - 33% more than in the previous edition in 2024 -, including 213 Spanish companies (+25%), and 68 foreign companies (+71%), from 12 countries. Hall 10 of IFEMA MADRID, with 22,000 m2 of gross area, and 9,855.5 m2 net area (+14%), hosted this offer and the extensive programme of conferences, which took place from February 26. (ifema.es).

?? Elanco maintains growth for the sixth consecutive quarter and exceeds innovation targets. Company records 4% revenue growth in the fourth quarter of 2024, driven by the Pet and Animal Health Production segments. In the fourth quarter, the company achieved a revenue of US$ 1.02 billion, a 4% increase driven by the advancement of the Pet and Animal Health Production segments. Not accumulated over the year, the company generated more than half a billion dollars in operational cash flow, or was registered in 2023. Among the highlights of the innovation pipeline, Elanco launched in the United States, or Credeli Quattro? in January. The canine atopic dermatitis medication Zenrelia? has expanded its presence to new markets, including Canada, Japan and Brazil, reaching almost 30% penetration in the United States. (portaldoagronegocio.com.br, Mar. 7th).

?? Elanco launched a drug in Brazil to treat symptoms of Chronic Renal Disease (CRD) in cats. Studies suggest that 30% of cats over 15 years of age present some serious illness. Elura was launched in Brazil, and is an innovative medicine, developed for the management of weight loss associated with chronic kidney disease (CKD) in cats, with a focus on stimulating appetite and weight gain. (caesegatos.com.br, Feb. 24th).

?? Elanco Animal Health Incorporated reported its financial results for the full year 2024. Revenue was $4,439 million, flat to prior year on a reported basis (up 3% on an organic constant currency basis). Reported net income was $338 million, compared to a net loss of $(1,231) million in 2023. (company press release).

?? Elanco Animal Health Incorporated announced the launch of Pet Protect, a line of veterinary-formulated supplements for dogs and cats. Pet Protect offers a full line of supplements, including products promoting healthy skin, helping to support situational stress, and supporting joint health and immune function. (company press release).

?? Elanco Animal Health Incorporated announced it has entered into an agreement with Medgene to leverage the company's innovative vaccine platform technology, including commercialization of a highly pathogenic avian influenza (HPAI) vaccine for use in dairy cattle. Medgene reports that the vaccine has met all requirements of the USDA’s platform technology guidelines and is in the final stages of review for conditional license approval. (company press release).

?? Zoetis announced that the USDA) Center for Veterinary Biologics (CVB) has issued the company a conditional license for its Avian Influenza Vaccine, H5N2 Subtype, Killed Virus. The vaccine is labeled for use in chickens. (company press release).

?? Veterquímica Chile continues to advance in its alliance with BioPoint by introducing a new portfolio of phytotherapeutic products for poultry and pigs from the new Veternatural line, developed to improve health and productive performance, contributing to the reduction of the use of antibiotics in the industry, with the support of science and the power of natural extracts. BioPoint, a Polish company dedicated to the development and production of food supplements based on natural phytotherapeutics and concentrates with its patented ALL-IN technology, with which they ensure standardized raw materials and constant concentrations of active ingredients. These products are incorporated into our new Veternatural Line, which aims to be a constant support in times of stress, vaccination processes and support for antimicrobial therapies. (Company Linkedin, Feb.).

?? Kradle introduced Cat Wellness Licks, representing its expansion into the feline market. The click-and-lick product line includes three functional solutions with varying levels of Cannabidiol (CBD) and a non-CBD formula; targeting Urinary Health, Skin & Allergy Support, and Hairball Control. (petfoodprocessing.com).

?? Mervue Laboratories was present at VIV Asia 2025 in Bangkok, March 12-14. The most professional expert team of nutritionists to support their cutting-edge solutions support the health and performance of young animals. Mervue is a growing innovative Irish nutraceutical company developing products for early life nutrition, and the future of animal health with highly differentiated products (Company's Linkedin).

?? SOUTH AFRICA ECO Animal Health Group plc announced the disposal of certain non-core product lines to its distribution partner in South Africa. The ECOmectin licenses disposed of in the transaction are for use in sheep and cattle and include a range of anti-parasitic treatments and have for some time been non-core to ECO. All licenses are specific to Southern Africa (South Africa, Botswana, Namibia and Zambia). (company press release).

?? The FDA announced it has approved Hikma Pharmaceuticals USA's generic Tulathromycin Injection for cattle and swine. Hikma is a manufacturer of human and animal health pharmaceuticals worldwide. (FDA).

?? Norbrook Laboratories ltd announced two new appointments to their global marketing team. Erwan Strullu as Global Marketing Director responsible for Norbrook’s future category & portfolio strategy and new product development. In addition Juliana Carrer joins as Global Marketing Category Manager for Companion Animal. Juliana will focus on developing and executing category-specific marketing strategies and commercial initiatives that align with Norbrook’s business objectives. (Company′s Linkedin).

Dr. MBA Bernardo Otero,

Subscribe on LinkedIn https://www.dhirubhai.net/build-relation/newsletter-follow?entityUrn=6862344212038328321

BERNARDO OTERO Animal Health Business leadership in LATIN AMERICA

CEO & Founder of NEXUS ANIMAL HEALTH